These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1325369)

  • 1. Blockade of GABAB receptors accelerates amygdala kindling development.
    Karlsson G; Klebs K; Hafner T; Schmutz M; Olpe HR
    Experientia; 1992 Aug; 48(8):748-51. PubMed ID: 1325369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baclofen prevents rapid amygdala kindling in adult rats.
    Wurpel JN
    Experientia; 1994 May; 50(5):475-8. PubMed ID: 8194584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors.
    Waldmeier PC; Wicki P; Feldtrauer JJ; Mickel SJ; Bittiger H; Baumann PA
    Br J Pharmacol; 1994 Dec; 113(4):1515-21. PubMed ID: 7889310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of GABAB receptor antagonism on the development of pentylenetetrazol-induced kindling in mice.
    Getova D; Froestl W; Bowery NG
    Brain Res; 1998 Nov; 809(2):182-8. PubMed ID: 9853109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABAB receptors in various in vitro and in vivo models of epilepsy: a study with the GABAB receptor blocker CGP 35348.
    Karlsson G; Kolb C; Hausdorf A; Portet C; Schmutz M; Olpe HR
    Neuroscience; 1992; 47(1):63-8. PubMed ID: 1315938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABAB receptor-mediated inhibition of GABAA receptor calcium elevations in developing hypothalamic neurons.
    Obrietan K; van den Pol AN
    J Neurophysiol; 1998 Mar; 79(3):1360-70. PubMed ID: 9497417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CGP 35348: a centrally active blocker of GABAB receptors.
    Olpe HR; Karlsson G; Pozza MF; Brugger F; Steinmann M; Van Riezen H; Fagg G; Hall RG; Froestl W; Bittiger H
    Eur J Pharmacol; 1990 Oct; 187(1):27-38. PubMed ID: 2176979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination of post- and presynaptic GABAB receptor-mediated responses by tetrahydroaminoacridine in area CA3 of the rat hippocampus.
    Lambert NA; Wilson WA
    J Neurophysiol; 1993 Feb; 69(2):630-5. PubMed ID: 8096243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of baclofen-induced hypothermia in mice by the novel GABAB antagonist CGP 35348.
    Jackson HC; Nutt DJ
    Neuropharmacology; 1991 May; 30(5):535-8. PubMed ID: 1650930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes.
    Gemignani A; Paudice P; Bonanno G; Raiteri M
    Mol Pharmacol; 1994 Sep; 46(3):558-62. PubMed ID: 7935338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal partial kindling decreased hippocampal GABAB receptor efficacy and wet dog shakes in rats.
    Leung LS; Shen B
    Behav Brain Res; 2006 Oct; 173(2):274-81. PubMed ID: 16887203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of new potent GABAB receptor antagonists in the hemisected spinal cord preparation of the rat.
    Brugger F; Wicki U; Olpe HR; Froestl W; Mickel S
    Eur J Pharmacol; 1993 Apr; 235(1):153-5. PubMed ID: 8390938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed antagonists at GABAB receptors that inhibit adenylyl cyclase in cerebellar granule cell cultures of rat.
    Holopainen I; Rau C; Wojcik WJ
    Eur J Pharmacol; 1992 Oct; 227(2):225-8. PubMed ID: 1330652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of intraperitoneal and intracerebroventricular administration of the GABAB receptor antagonist CGP 35348 on food intake in rats.
    Patel SM; Ebenezer IS
    Eur J Pharmacol; 2004 Oct; 503(1-3):89-93. PubMed ID: 15496301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory effects of baclofen and 3-aminopropylphosphinic acid in guinea-pigs.
    Hey JA; Mingo G; Bolser DC; Kreutner W; Krobatsch D; Chapman RW
    Br J Pharmacol; 1995 Feb; 114(4):735-8. PubMed ID: 7773531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baclofen inhibits amygdala kindling in immature rats.
    Wurpel JN; Sperber EF; Moshé SL
    Epilepsy Res; 1990; 5(1):1-7. PubMed ID: 2303019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-amino-2-(4-chlorophenyl)-nitropropane is a new GABAB receptor agonist, more active peripherally.
    Kerr DI; Ong J; Doolette DJ; Abbenante J; Prager RH
    Eur J Pharmacol; 1993 May; 236(2):239-45. PubMed ID: 8391459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological actions of GABAB agonists and antagonists in rat dorso-lateral septal neurones in vitro.
    Bon C; Galvan M
    Br J Pharmacol; 1996 Jun; 118(4):961-7. PubMed ID: 8799569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenaline release in the rat vena cava is inhibited by gamma-aminobutyric acid via GABAB receptors but not affected by histamine.
    Schneider D; Schlicker E; Malinowska B; Molderings G
    Br J Pharmacol; 1991 Oct; 104(2):478-82. PubMed ID: 1665738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPSP amplitude modulation at the rat Ia-alpha motoneuron synapse: effects of GABAB receptor agonists and antagonists.
    Peshori KR; Collins WF; Mendell LM
    J Neurophysiol; 1998 Jan; 79(1):181-9. PubMed ID: 9425189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.